132 related articles for article (PubMed ID: 35964532)
1. Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome.
Rallo MS; Akel O; Kalakoti P; Sun H
J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106705. PubMed ID: 35964532
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with in-hospital complications for pediatric sickle-cell disease-associated moyamoya syndrome: a nationwide cross-sectional study.
Osorio RC; Raygor KP; Rinaldo L; Fox CK; Bhasin N; Abla AA; Gupta N
Childs Nerv Syst; 2024 Jul; 40(7):2109-2114. PubMed ID: 38530413
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
[TBL] [Abstract][Full Text] [Related]
4. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
6. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
7. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
[TBL] [Abstract][Full Text] [Related]
8. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
9. Comparison between moyamoya disease and moyamoya syndrome in Israel.
Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012.
Baker C; Grant AM; George MG; Grosse SD; Adamkiewicz TV
Pediatr Blood Cancer; 2015 Dec; 62(12):2076-81. PubMed ID: 26174777
[TBL] [Abstract][Full Text] [Related]
11. Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome.
Birkeland P; Gardner K; Kesse-Adu R; Davies J; Lauritsen J; Rom Poulsen F; Tolias CM; Thein SL
Stroke; 2016 Jul; 47(7):1710-3. PubMed ID: 27301940
[TBL] [Abstract][Full Text] [Related]
12. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.
McCavit TL; Xuan L; Zhang S; Flores G; Quinn CT
Pediatr Blood Cancer; 2013 May; 60(5):823-7. PubMed ID: 23151905
[TBL] [Abstract][Full Text] [Related]
13. Moyamoya syndrome as a risk factor for stroke in Saudi children. Novel and usual associations.
Salih MA; Murshid WR; Al-Salman MM; Abdel-Gader AG; Al-Jarallah AA; Alorainy IA; Hassan HH; Kentab AY; Van Maldergem L; Othman SA; El-Desouki MI; Elgamal EA
Saudi Med J; 2006 Mar; 27 Suppl 1():S69-80. PubMed ID: 16532134
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
[TBL] [Abstract][Full Text] [Related]
15. Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience.
Zayed AM; Al-Muhaimeed S; Al-Otaibi T; Ali EM; Saleh R; Ancheta SJ; Al-Harbi F; Waheed KB; Albahli Y; Alghamdi H
Cureus; 2023 Nov; 15(11):e49039. PubMed ID: 38024048
[TBL] [Abstract][Full Text] [Related]
16. Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome.
Das S; Ray BK; Pandit A; Ghosh R; Chakraborty AP; Dubey S
Eur J Paediatr Neurol; 2022 Nov; 41():63-70. PubMed ID: 36368232
[TBL] [Abstract][Full Text] [Related]
17. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
[TBL] [Abstract][Full Text] [Related]
18. Trends in comorbid sickle cell disease among stroke patients.
Ovbiagele B; Adams RJ
J Neurol Sci; 2012 Feb; 313(1-2):86-91. PubMed ID: 21992814
[TBL] [Abstract][Full Text] [Related]
19. Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency.
Saxena P; Alkaissi H; Chauhan R; Muthu J
Cureus; 2023 Jan; 15(1):e34314. PubMed ID: 36860230
[TBL] [Abstract][Full Text] [Related]
20. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
Dobson SR; Holden KR; Nietert PJ; Cure JK; Laver JH; Disco D; Abboud MR
Blood; 2002 May; 99(9):3144-50. PubMed ID: 11964276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
